Villagrán-García, Macarena http://orcid.org/0000-0001-9236-2428
Muñiz-Castrillo, Sergio http://orcid.org/0000-0001-5958-3288
Ciano-Petersen, Nicolás Lundahl http://orcid.org/0000-0001-9555-4847
Vogrig, Alberto http://orcid.org/0000-0002-3652-7061
Farina, Antonio http://orcid.org/0000-0002-5551-0185
Villard, Marine http://orcid.org/0000-0002-1061-2321
Psimaras, Dimitri
Alentorn, Agusti http://orcid.org/0000-0002-7220-2686
Gonçalves, David
Fabien, Nicole
Rogemond, Véronique http://orcid.org/0000-0003-2098-920X
Joubert, Bastien http://orcid.org/0000-0003-4631-3056
Honnorat, Jérôme
Funding for this research was provided by:
Agence nationale de la recherche (ANR-18-RHUS-0012)
Article History
Received: 20 June 2022
Revised: 24 August 2022
Accepted: 25 August 2022
First Online: 1 September 2022
Declarations
:
: Macarena Villagrán-García received a fellowship grant from the Spanish Society of Neurology.
: The authors declare no conflict of interest.
: All patients recruited in the French Reference Centre on Paraneoplastic Neurologic Syndromes and Autoimmune Encephalitis (Lyon, France) provided written informed consent for the storage and use of their serum and cerebrospinal fluid (CSF) samples and clinical information for research purposes. The Institutional Review Board of the <i>Université Claude Bernard Lyon 1</i> and <i>Hospices Civils de Lyon</i> approved the study (GenePNS, 19-62, NCT-03963700). The study was performed in accordance with the ethical standards framed by the Declaration of Helsinki and its later amendments.